Ascendis Pharma A (ASND) Change in Intangibles (2020 - 2021)

Ascendis Pharma A (ASND) reported Change in Intangibles of -$639305.1 for Q1 2021, up 44.03% sequentially from -$1.1 million in Q4 2020.

Ascendis Pharma A (ASND) Change in Intangibles (2020 - 2021) Analysis & Trends

Ascendis Pharma A (ASND) has 2 years of Change in Intangibles data on file, last reported at -$639305.1 in Q1 2021.

For the quarter ending Q1 2021, Change in Intangibles changed N/A year-over-year to -$639305.1; the trailing twelve-month figure through Dec 2021 stood at -$639305.1 (changed N/A YoY), and the FY2021 full-year result was -$606304.6, up 69.95% from the prior year.
Change in Intangibles climbed to -$639305.1 in Q1 2021, from -$1.1 million in the prior quarter.
In the past five years, Change in Intangibles ranged from a high of -$494096.7 in Q3 2020 to a low of -$1.1 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Intangibles (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	-
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Ascendis Pharma A	15.35 Bn	14.68 Bn	268.20 Mn	-

Download Data